CARDIOVASCULAR
hamburger

A UNIQUE APPROACH TO HEART FAILURE MANAGEMENT

If you have NYHA Class III heart failure and have been hospitalized in the past year, it may be time to talk to your doctor about a unique approach to heart failure management designed for people like you. It’s called the CardioMEMS™ HF System.

The CardioMEMS HF System is an FDA-approved pulmonary artery pressure monitor that can improve your quality of life, and even reduce your risk for hospitalization.1

proactive heart failure management
reduce risk for hospitilization
potentially fewer doctor visits

HOW CAN THE CARDIOMEMS™ HF SYSTEM HELP YOU STAY AHEAD OF HEART FAILURE?

Pulmonary artery (PA) pressure monitoring provides early detection of worsening heart failure, long before symptoms such as weight gain or blood pressure. Daily pulmonary pressure readings can proactively inform your care team of any needed adjustments to your medications and/or lifestyle without a hospital or clinic visit.

HOW DOES PA PRESSURE MONITORING WORK?

  • A tiny pressure-sensor is inserted into your pulmonary artery through a short, low-risk procedure.
  • You simply take a daily measurement of the sensor from the comfort of your home.
  • Your healthcare provider reviews the information received from the sensor and contacts you if changes to your medications or treatment plan are necessary.
  • Regular monitoring from your home allows you and your heart failure medical team to get ahead of heart failure before it progresses.

Watch the video below to see how the CardioMEMS HF System works

Improved quality of life

 

find a clinic

find a clinic

find a clinic

 

SEE IF YOU QUALIFY

You may qualify for a new trial to better manage your symptoms remotely from home.

CARDIOMEMS HF SYSTEM RECIPIENT STORIES
GETTING BACK OUT THERE: LEWIS’S CARDIOMEMS™ HF SYSTEM STORY

Lewis and his wife Amy discuss how he feels with the CardioMEMS™ HF System.

 

 

RENEWED ENERGY AND PEACE OF MIND: IRIS’ CARDIOMEMS™ HF SYSTEM STORY

After receiving the CardioMEMS HF System, Iris has gained so much energy and peace of mind. She's back to playing with her grandchildren and cheering for her favorite football team.

 

 

STAYING INVOLVED WITH LIFE: CYNTHIA C’S CARDIOMEMS™ HF SYSTEM STORY

Cynthia explains how getting the CardioMEMS HF System has increased communication with her heart failure care team and given her a sense of reassurance and peace.



RESOURCES

HAVE YOU HEARD ABOUT THE CARDIOMEMS™ HF SYSTEM AMBASSADOR PROGRAM?

CardioMEMS HF System Ambassadors and their caregivers volunteer their time to share their story with others who have heart failure because they understand first-hand the journey of heart failure. Watch some of their stories in the video section above, or call 855-4-CMEMSHF to speak with an Ambassador.

GETTING STARTED

 

REFERENCE

1. Abraham, W. T., Stevenson, L. W., Bourge, R. C., Lindenfeld, J. A., Bauman, J. G., Adamson, P. B., for the CHAMPION Trial Study Group. (2016). Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. The Lancet, 387(10017), 453-461.

INDICATIONS, SAFETY & WARNINGS

INDICATIONS, SAFETY & WARNINGS

Rx Only

Brief Summary: Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use.

Indications and Usage: The CardioMEMS™ HF System is indicated for wirelessly measuring and monitoring pulmonary artery (PA) pressure and heart rate in New York Heart Association (NYHA) Class III heart failure patients who have been hospitalized for heart failure in the previous year. The hemodynamic data are used by physicians for heart failure management and with the goal of reducing heart failure hospitalizations.

Contraindications: The CardioMEMS HF System is contraindicated for patients with an inability to take dual antiplatelet or anticoagulants for one-month post implant.

Potential Adverse Events: Potential adverse events associated with the implantation procedure include, but are not limited to, the following: infection, arrhythmias, bleeding, hematoma, thrombus, myocardial infarction, transient ischemic attack, stroke, death and device embolization.

SJM-CV WEB-0718-0003(1)

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?

true
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?